The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte NEIL H. BANDER
___________
Appeal No. 2006-03521
Application No. 09/929,546
________
ON BRIEF2
__________
Before SCHEINER, MILLS and GRIMES, Administrative Patent Judges.
SCHEINER, Administrative Patent Judge.
DECISION ON APPEAL
This appeal involves a method of treating non-prostate cancer by administering
monoclonal antibodies that bind prostate specific membrane antigen (PSMA). The
examiner has rejected claims requiring a particular subgenus of anti-PSMA antibodies
as lacking adequate written descriptive support. We have jurisdiction under 35 U.S.C. §
134. We will reverse this rejection because we find that appellant’s disclosure conveys
with reasonable clarity to those skilled in the art that, as of the filing date, appellant was
in possession of the claimed invention.
1 This appeal is related to appeals in related application nos. 09/357,709 (appeal
no. 2006-0633), 09/357,710 (appeal no. 2006-1520) and 09/929,665 (appeal no. 2006-
0632). We have considered these appeals together.
2 Appellant requested an oral hearing in this case, however, after reviewing the
case, we have determined that an oral hearing will not be necessary and have rendered
a decision based on the record. See 37 CFR §§ 41.47(a),(f).
Page: 1 2 3 4 5 6 7 Next
Last modified: November 3, 2007